590 related articles for article (PubMed ID: 24456746)
1. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
2. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
3. Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice.
Zhang CT; Lin JR; Wu F; Ghosh A; Tang SS; Hu M; Long Y; Sun HB; Hong H
Neurotoxicology; 2016 Dec; 57():214-222. PubMed ID: 27702591
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
Tang SS; Hong H; Chen L; Mei ZL; Ji MJ; Xiang GQ; Li N; Ji H
Neurobiol Aging; 2014 Mar; 35(3):590-9. PubMed ID: 24269024
[TBL] [Abstract][Full Text] [Related]
5. Chotosan improves Aβ1-42-induced cognitive impairment and neuroinflammatory and apoptotic responses through the inhibition of TLR-4/NF-κB signaling in mice.
Chen L; Hu L; Zhao J; Hong H; Feng F; Qu W; Liu W
J Ethnopharmacol; 2016 Sep; 191():398-407. PubMed ID: 26994819
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with antiasthmatic drug ibudilast ameliorates Aβ 1-42-induced memory impairment and neurotoxicity in mice.
Wang H; Mei Zl; Zhong KL; Hu M; Long Y; Miao MX; Li N; Yan TH; Hong H
Pharmacol Biochem Behav; 2014 Sep; 124():373-9. PubMed ID: 25038445
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice.
Tang SS; Wang XY; Hong H; Long Y; Li YQ; Xiang GQ; Jiang LY; Zhang HT; Liu LP; Miao MX; Hu M; Zhang TT; Hu W; Ji H; Ye FY
Neuropharmacology; 2013 Feb; 65():182-92. PubMed ID: 22982445
[TBL] [Abstract][Full Text] [Related]
8. CysLT
Ghosh A; Chen F; Wu F; Tang SS; Hu M; Long Y; Sun HB; Kong LY; Hong H
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():19-30. PubMed ID: 27720931
[TBL] [Abstract][Full Text] [Related]
9. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.
Sachdeva AK; Chopra K
J Nutr Biochem; 2015 Jul; 26(7):736-44. PubMed ID: 25869595
[TBL] [Abstract][Full Text] [Related]
10. PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice.
An YQ; Zhang CT; Du Y; Zhang M; Tang SS; Hu M; Long Y; Sun HB; Hong H
Metab Brain Dis; 2016 Jun; 31(3):663-71. PubMed ID: 26864581
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of pranlukast on Aβ₁₋₄₂-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1.
Tang SS; Ji MJ; Chen L; Hu M; Long Y; Li YQ; Miao MX; Li JC; Li N; Ji H; Chen XJ; Hong H
Int J Neuropsychopharmacol; 2014 Apr; 17(4):581-92. PubMed ID: 24229499
[TBL] [Abstract][Full Text] [Related]
12. Preventive effect of genetic knockdown and pharmacological blockade of CysLT
Chen F; Ghosh A; Wu F; Tang S; Hu M; Sun H; Kong L; Hong H
Brain Behav Immun; 2017 Feb; 60():255-269. PubMed ID: 27810377
[TBL] [Abstract][Full Text] [Related]
13. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of INT-777 against Aβ
Wu X; Lv YG; Du YF; Chen F; Reed MN; Hu M; Suppiramaniam V; Tang SS; Hong H
Brain Behav Immun; 2018 Oct; 73():533-545. PubMed ID: 29935310
[TBL] [Abstract][Full Text] [Related]
15. The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats.
Wang C; Yang XM; Zhuo YY; Zhou H; Lin HB; Cheng YF; Xu JP; Zhang HT
Int J Neuropsychopharmacol; 2012 Jul; 15(6):749-66. PubMed ID: 21733236
[TBL] [Abstract][Full Text] [Related]
16. Xanthoceraside attenuates amyloid β peptide
Qi Y; Ji XF; Chi TY; Liu P; Jin G; Xu Q; Jiao Q; Wang LH; Zou LB
Eur J Pharmacol; 2018 Feb; 820():18-30. PubMed ID: 29229533
[TBL] [Abstract][Full Text] [Related]
17. Pratensein ameliorates β-amyloid-induced cognitive impairment in rats via reducing oxidative damage and restoring synapse and BDNF levels.
Liang C; Tan S; Huang Q; Lin J; Lu Z; Lin X
Neurosci Lett; 2015 Apr; 592():48-53. PubMed ID: 25748315
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of mogrol against Aβ
Chen G; Liu C; Meng G; Zhang C; Chen F; Tang S; Hong H; Zhang C
J Pharm Pharmacol; 2019 May; 71(5):869-877. PubMed ID: 30585314
[TBL] [Abstract][Full Text] [Related]
19. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
